RxDoctor Payments Data

Anthony Cacco, MD

Family Medicine · Rochester Hills, MINPI 1508009192

Payments from drug & device makers

$382in general payments, 2019–2025

Across 24 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$124
  • GSK$94
  • AbbVie$81
  • Novo Nordisk$22
  • Merck$19
  • Almatica Pharma LLC$16
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$382100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen8$124
GSK6$94
AbbVie5$81
Novo Nordisk1$22
Merck1$19
Almatica Pharma LLC1$16
Johnson & Johnson1$13
Pfizer1$12

How this compares

$382 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$132,593
Medicare patients
181
Services billed
2,753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$44,411
EliquisApixaban48$43,520
OzempicSemaglutide27$34,979
XareltoRivaroxaban17$25,102
RybelsusSemaglutide12$18,555
ArexvyRsvpref3 Antigen/As01e/Pf40$12,388
Atorvastatin Calcium392$5,165
ShingrixVaricella-Zoster Ge/As01b/Pf19$4,156
Tamsulosin Hcl141$3,074
Boostrix TdapDiphth,pertuss(Acell),tet Vac32$2,338
Losartan Potassium196$2,246
Quetiapine Fumarate46$2,081
Colestipol Hcl17$1,752
Buspirone Hcl47$1,714
Levothyroxine Sodium186$1,709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$22$53,53439 claims
PfizerEliquis, Paxlovid$12$44,80162 claims
Johnson & JohnsonXarelto$13$25,10217 claims
GSKArexvy, Shingrix$94$16,54359 claims
Almatica Pharma LLCSertraline Hcl$16$89796 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →